Oxidative Stress and Renal Fibrosis: Recent Insights for the Development of Novel Therapeutic Strategies

Wenshan Lv; George W. Booz; Fan Fan; Yangang Wang; Richard J. Roman

doi:10.3389/fphys.2018.00105

journal article Open Access Feb 16, 2018

Oxidative Stress and Renal Fibrosis: Recent Insights for the Development of Novel Therapeutic Strategies

Wenshan Lv

George W. Booz

Fan Fan

Yangang Wang Richard J. Roman

Frontiers in Physiology Vol. 9 · Frontiers Media SA

View at Publisher Save 10.3389/fphys.2018.00105

Topics

No keywords indexed for this article. Browse by subject →

References

116

[1]

An "Salvia miltiorrhiza lipophilic fraction attenuates oxidative stress in diabetic nephropathy through activation of nuclear factor erythroid 2-Related factor 2" Am. J. Chin. Med. (2017) 10.1142/s0192415x17500781

[2]

Baltanas "A synthetic peptide from transforming growth factor-beta(1) type III receptor inhibits NADPH oxidase and prevents oxidative stress in the kidney of spontaneously hypertensive rats" Antioxid. Redox Signal (2013) 10.1089/ars.2012.4653

[3]

Baylis "Nitric oxide deficiency in chronic kidney disease" Am. J. Physiol. Renal Physiol. (2008) 10.1152/ajprenal.00424.2007

[4]

Bondi "NAD(P)H oxidase mediates TGF-beta1-induced activation of kidney myofibroblasts" J. Am. Soc. Nephrol. (2010) 10.1681/asn.2009020146

[5]

Chatuphonprasert "Improvement of superoxide dismutase and catalase in streptozotocin-nicotinamide-induced type 2-diabetes in mice by berberine and glibenclamide" Pharm. Biol (2014) 10.3109/13880209.2013.839714

[6]

Chen "CYP2J2 and EETs protect against oxidative stress and apoptosis in vivo and in vitro following lung ischemia/reperfusion" Cell. Physiol. Biochem. (2014) 10.1159/000362950

[7]

Chen "Curcumin-loaded nanoparticles protect against rhabdomyolysis-induced acute kidney injury" Cell. Physiol. Biochem. (2017) 10.1159/000484233

[8]

Chen "Radix puerariae and fructus crataegi mixture inhibits renal injury in type 2 diabetes via decreasing of AKT/PI3K" BMC Complement. Altern. Med. (2017) 10.1186/s12906-017-1945-3

[9]

Chien "Renal function and metabolic syndrome components on cardiovascular and all-cause mortality" Atherosclerosis (2008) 10.1016/j.atherosclerosis.2007.07.037

[10]

Choi "Effect of redox modulating NRF2 activators on chronic kidney disease" Molecules (2014) 10.3390/molecules190812727

[11]

Chow "Relaxin signals through a RXFP1-pERK-nNOS-NO-cGMP-dependent pathway to up-regulate matrix metalloproteinases: the additional involvement of iNOS" PLoS ONE (2012) 10.1371/journal.pone.0042714

[12]

Chow "Relaxin requires the angiotensin II type 2 receptor to abrogate renal interstitial fibrosis" Kidney Int. (2014) 10.1038/ki.2013.518

[13]

Collino "Acute treatment with relaxin protects the kidney against ischaemia/reperfusion injury" J. Cell. Mol. Med. (2013) 10.1111/jcmm.12120

[14]

Danielson "Relaxin improves renal function and histology in aging Munich Wistar rats" J. Am. Soc. Nephrol. (2006) 10.1681/asn.2005121307

[15]

Declèves "Novel targets of antifibrotic and anti-inflammatory treatment in CKD" Nat. Rev. Nephrol. (2014) 10.1038/nrneph.2014.31

[16]

Dell'Agli "Potent inhibition of human phosphodiesterase-5 by icariin derivatives" J. Nat. Prod. (2008) 10.1021/np800049y

[17]

De Zeeuw "Rationale and trial design of bardoxolone methyl evaluation in patients with chronic kidney disease and Type 2 diabetes: the occurrence of renal events (BEACON)" Am. J. Nephrol. 10.1159/000346948

[18]

Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease

Dick de Zeeuw, Tadao Akizawa, Paul Audhya et al.

New England Journal of Medicine 10.1056/nejmoa1306033

[19]

dong "Effect of triptolide on expression of oxidative carbonyl protein in renal cortex of rats with diabetic nephropathy" J. Huazhong Univ. Sci. Technol. Med. Sci. (2017) 10.1007/s11596-017-1689-9

[20]

Dschietzig "Relaxin improves TNF-alpha-induced endothelial dysfunction: the role of glucocorticoid receptor and phosphatidylinositol 3-kinase signalling" Cardiovasc. Res. (2012) 10.1093/cvr/cvs149

[21]

Fang "Fufang Xue Shuan Tong capsules inhibit renal oxidative stress markers and indices of nephropathy in diabetic rats" Exp. Ther. Med. (2012) 10.3892/etm.2012.680

[22]

Firoozi "In vivo and in vitro response of corpus cavernosum to phosphodiesterase-5 inhibition in the hypercholesterolaemic rabbit" BJU Int. (2005) 10.1111/j.1464-410x.2005.05588.x

[23]

(2014)

[24]

Granata "Mitochondrial dysregulation and oxidative stress in patients with chronic kidney disease" BMC Genomics (2009) 10.1186/1471-2164-10-388

[25]

NADPH Oxidase 1 Plays a Key Role in Diabetes Mellitus–Accelerated Atherosclerosis

Stephen P. Gray, Elyse Di Marco, Jun Okabe et al.

Circulation 2013 10.1161/circulationaha.112.132159

[26]

Gumieniczek "Effect of the new thiazolidinedione-pioglitazone on the development of oxidative stress in liver and kidney of diabetic rabbits" Life Sci. (2003) 10.1016/j.lfs.2003.03.004

[27]

Hallan "Long-term trends in the prevalence of chronic kidney disease and the influence of cardiovascular risk factors in Norway" Kidney Int. (2016) 10.1016/j.kint.2016.04.012

[28]

Ho "Curcumin rescues diabetic renal fibrosis by targeting superoxide-mediated wnt signaling pathways" Am. J. Med. Sci. (2016) 10.1016/j.amjms.2015.12.017

[29]

Holterman "Nox and renal disease" Clin. Sci. 10.1042/cs20140361

[30]

Holterman "NADPH oxidase 5 and renal disease" Curr. Opin. Nephrol. Hypertens. 10.1097/mnh.0000000000000081

[31]

Holterman "Nephropathy and elevated BP in mice with podocyte-specific NADPH oxidase 5 expression" J. Am. Soc. Nephrol. (2014) 10.1681/asn.2013040371

[32]

Hsieh "Prescribed renoprotective chinese herbal medicines were associated with a lower risk of all-cause and disease-specific mortality among patients with chronic kidney disease: a population-based follow-up study in taiwan" Evid. Based Complement. Alternat. Med. (2017) 10.1155/2017/5632195

[33]

Imig "Epoxide hydrolase and epoxygenase metabolites as therapeutic targets for renal diseases" Am. J. Physiol. Renal Physiol. (2005) 10.1152/ajprenal.00350.2004

[34]

Actions of epoxygenase metabolites on the preglomerular vasculature.

J D Imig, L G Navar, R J Roman et al.

Journal of the American Society of Nephrology 1996 10.1681/asn.v7112364

[35]

Jeong "Effects of sildenafil on oxidative and inflammatory injuries of the kidney in streptozotocin-induced diabetic rats" Am. J. Nephrol. (2009) 10.1159/000158635

[36]

Jiang "Berberine attenuates lipopolysaccharide-induced extracelluar matrix accumulation and inflammation in rat mesangial cells: involvement of NF-κB signaling pathway" Mol. Cell. Endocrinol. (2011) 10.1016/j.mce.2010.07.023

[37]

Jiménez-Osorio "The effect of dietary supplementation with curcumin on redox status and Nrf2 activation in patients with nondiabetic or diabetic proteinuric chronic kidney disease: a pilot study" J. Ren. Nutr. (2016) 10.1053/j.jrn.2016.01.013

[38]

Joy "Phase I trial of rosiglitazone in FSGS: I. Report of the FONT study group" Clin. J. Am. Soc. Nephrol (2009) 10.2215/cjn.02310508

[39]

Katagiri "Interstitial renal fibrosis due to multiple cisplatin treatments is ameliorated by semicarbazide-sensitive amine oxidase inhibition" Kidney Int. (2016) 10.1038/ki.2015.327

[40]

Khan "Epoxyeicosatrienoic acid analog attenuates angiotensin II hypertension and kidney injury" Front. Pharmacol. (2014) 10.3389/fphar.2014.00216

[41]

Khwaja "The management of CKD: a look into the future" Kidney Int. (2007) 10.1038/sj.ki.5002489

[42]

Kim "Inhibition of soluble epoxide hydrolase prevents renal interstitial fibrosis and inflammation" Am. J. Physiol. Renal Physiol. (2014) 10.1152/ajprenal.00256.2014

[43]

Kim "Pharmacological inhibition of soluble epoxide hydrolase prevents renal interstitial fibrogenesis in obstructive nephropathy" Am. J. Physiol. Renal Physiol. (2015) 10.1152/ajprenal.00531.2014

[44]

Koc-Zorawska "VAP-1, a novel molecule linked to endothelial damage and kidney function in kidney allograft recipients" Kidney Blood Press. Res. (2012) 10.1159/000343413

[45]

Kusunoki "Telmisartan exerts renoprotective actions via peroxisome proliferator-activated receptor-gamma/hepatocyte growth factor pathway independent of angiotensin II type 1 receptor blockade" Hypertension (2012) 10.1161/hypertensionaha.111.176263

[46]

Lan "Berberine attenuates high glucose-induced proliferation and extracellular matrix accumulation in mesangial cells: involvement of suppression of cell cycle progression and NF-κB/AP-1 pathways" Mol. Cell. Endocrinol. (2014) 10.1016/j.mce.2014.01.022

[47]

Lau "The effect of vardenafil (a PDE type 5 inhibitor) on renal function in the diabetic rabbit: a pilot study" In vivo (2007)

[48]

Lee "Delayed treatment with lithospermate B attenuates experimental diabetic renal injury" J. Am. Soc. Nephrol. (2003) 10.1097/01.asn.0000051660.82593.19

[49]

Lee "Therapeutic targets for treating fibrotic kidney diseases" Transl. Res. (2015) 10.1016/j.trsl.2014.07.010

[50]

Leo "Vascular actions of relaxin: nitric oxide and beyond" Br. J. Pharmacol. (2017) 10.1111/bph.13614

Showing 50 of 116 references

Cited By

136

Renal Implications of Dysregulated Protein Homeostasis: Insights into Ubiquitin–Proteasome and Autophagy Systems

Charlotte Delrue, Marijn M. Speeckaert · 2025

Biomolecules

Metrics

136

Citations

116

References

Details

Published: Feb 16, 2018
Vol/Issue: 9
License: View

Authors

W

Wenshan Lv

Department of Endocrinology and Metabolism, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China

G

George W. Booz

Department of Pharmacology and Toxicology (O.T.H., N.C., E.D., L.M.A., D.W., K.W., T.W.T., E.H.C., S.B., G.W.B., D.C.C., B.L.), University of Mississippi Medical Center, Jackson.

F

Fan Fan

State Key Laboratory of Pollution Control and Resource Reuse, School of the Environment; Nanjing University

Funding

National Institutes of Health Award: HL36279

National Natural Science Foundation of China Award: 81270939

Natural Science Foundation of Shandong Province Award: ZR2017MH069

American Heart Association Award: 16GRNT31200036

Cite This Article

Wenshan Lv, George W. Booz, Fan Fan, et al. (2018). Oxidative Stress and Renal Fibrosis: Recent Insights for the Development of Novel Therapeutic Strategies. Frontiers in Physiology, 9. https://doi.org/10.3389/fphys.2018.00105

Oxidative Stress and Renal Fibrosis: Recent Insights for the Development of Novel Therapeutic Strategies

You May Also Like